Portal de Periódicos da CAPES

Clinical Management of Squamous Cell Carcinoma of the Oropharynx: How Does This Differ for HPV-Related Tumors?

2013; Future Medicine; Volume: 9; Issue: 10 Linguagem: Inglês

10.2217/fon.13.121

1744-8301

Kristen B. Pytynia, Kristina R. Dahlstrom, Erich M. Sturgis,

Cancer-related molecular mechanisms research

Future OncologyVol. 9, No. 10 EditorialClinical management of squamous cell carcinoma of the oropharynx: how does this differ for HPV-related tumors?Kristen B Pytynia, Kristina R Dahlstrom & Erich M SturgisKristen B Pytynia* Author for correspondenceDepartment of Head & Neck Surgery, Unit 1445, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. , Kristina R DahlstromDepartment of Head & Neck Surgery, Unit 1445, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA & Erich M SturgisDepartment of Head & Neck Surgery, Unit 1445, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USADepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAPublished Online:9 Oct 2013https://doi.org/10.2217/fon.13.121AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: clinical trialhuman papillomavirusoropharyngeal cancertreatmentReferences1 Mehta V, Yu GP, Schantz SP. Population-based analysis of oral and oropharyngeal carcinoma: changing trends of histopathologic differentiation, survival and patient demographics. Laryngoscope120,2203–2212 (2010).Crossref, Medline, Google Scholar2 Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer110,1429–1435 (2007).Crossref, Medline, Google Scholar3 Chaturvedi AK, Engels EA, Pfeiffer RM et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol.29,4294–4301 (2011).Crossref, Medline, Google Scholar4 Mork J, Lie AK, Glattre E et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N. Engl. J. Med.344,1125–1131 (2001).Crossref, Medline, CAS, Google Scholar5 Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl Cancer Inst. Med.92,709–720 (2000).Crossref, Medline, CAS, Google Scholar6 Ang KK, Harris J, Wheeler R et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med.363,24–35 (2010).Crossref, Medline, CAS, Google Scholar7 Hariri S, Unger ER, Sternberg M et al. Prevalence of genital human papillomavirus among females in the United States, the national health and nutrition examination survey, 2003–2006. J. Infect. Dis.204,566–573 (2011).Crossref, Medline, Google Scholar8 Giuliano AR, Lazcano-Ponce E, Villa LL et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol. Biomarkers Prev.17,2036–2043 (2008).Crossref, Medline, CAS, Google Scholar9 Sturgis EM, Ang KK. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? J. Natl Compr. Canc. Netw.9,665–673 (2011).Crossref, Medline, Google Scholar10 Dahlstrom KR, Li G, Tortolero-Luna G, Wei Q, Sturgis EM. Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck33,847–855 (2011).Crossref, Medline, Google Scholar11 Hong AM, Martin A, Chatfield M et al. Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma. Int. J. Cancer132(12),2748–2754 (2012).Crossref, Medline, Google Scholar12 Gillison ML, D'Souza G, Westra W et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J. Natl Cancer Inst. Med.100,407–420 (2008).Crossref, Medline, Google Scholar13 D'Souza G, Kreimer AR, Viscidi R et al. Case–control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med.356,1944–1956 (2007).Crossref, Medline, Google Scholar14 O'Sullivan B, Huang SH, Perez-Ordonez B et al. Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother. Oncol.103,49–56 (2012).Crossref, Medline, Google Scholar15 Baxi SS, Shuman AG, Corner GW et al. Sharing a diagnosis of HPV-related head and neck cancer: the emotions, the confusion, and what patients want to know. Head Neck doi:10.1002/hed.23182 (Epub ahead of print) (2012).Medline, Google Scholar16 Chu A, Genden E, Posner M, Sikora A. A patient-centered approach to counseling patients with head and neck cancer undergoing human papillomavirus testing: a clinician's guide. Oncologist18,180–189 (2013).Crossref, Medline, Google Scholar17 Ang KK, Sturgis EM. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin. Radiat. Oncol.22,128–142 (2012).Crossref, Medline, Google Scholar18 Pytynia KB, Grant JR, Etzel CJ, Roberts DB, Wei Q, Sturgis EM. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J. Clin. Oncol.22,3981–3988 (2004).Crossref, Medline, Google Scholar19 Fakhry C, Westra WH, Li S et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl Cancer Inst. Med.100,261–269 (2008).Crossref, Medline, CAS, Google Scholar20 O'Sullivan B, Huang SH, Siu LL et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J. Clin. Oncol.31,543–550 (2013).Crossref, Medline, Google Scholar21 Huang SH, Perez-Ordonez B, Weinreb I et al. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol.49,79–85 (2013).Crossref, Medline, Google Scholar22 Huang SH, Perez-Ordonez B, Liu FF et al. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.82,276–283 (2012).Crossref, Medline, Google Scholar23 Muller S, Khuri FR, Kono SA, Beitler JJ, Shin DM, Saba NF. HPV positive squamous cell carcinoma of the oropharynx. Are we observing an unusual pattern of metastases? Head Neck Pathol.6,336–344 (2012).Crossref, Medline, Google Scholar24 Peck BW, Dahlstrom KR, Gan SJ et al. Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck35,794–799 (2012).Crossref, Medline, Google Scholar25 Jain KS, Sikora AG, Baxi SS, Morris LG. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer. Cancer119,1832–1837 (2013).Crossref, Medline, Google ScholarFiguresReferencesRelatedDetailsCited ByNatural history of untreated squamous cell carcinoma of the head and neck27 December 2018 | Clinical Otolaryngology, Vol. 44, No. 2Dynamic contrast-enhanced MRI detects acute radiotherapy-induced alterations in mandibular microvasculature: prospective assessment of imaging biomarkers of normal tissue injury8 August 2016 | Scientific Reports, Vol. 6, No. 1Oropharyngeal squamous cell carcinoma in the veteran population: Association with traditional carcinogen exposure and poor clinical outcomes4 July 2015 | Head & Neck, Vol. 37, No. 9 Vol. 9, No. 10 STAY CONNECTED Metrics Downloaded 250 times History Published online 9 October 2013 Published in print October 2013 Information© Future Medicine LtdKeywordsclinical trialhuman papillomavirusoropharyngeal cancertreatmentAcknowledgementsThe authors wish to thank SP Deming of the Department of Scientific Publications, The University of Texas MD Anderson Cancer Center for assistance with manuscript editing.Financial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download